风险分层的分类树的方法审查:肥胖悖论中的应用例子
Javier Trujillano1, Luis Serviá1, Mariona Badia1
1IRBLLeida (Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré), Av. Alcalde Rovira Roure, 80, 25198 Lleida, Spain.
Nutrients
|June 13, 2025
概括
分类树 (CTs) 通过发现复杂的模式来增强临床风险分层. 虽然像XGBoost这样的组合CT提供了高精度,但简单的CT和SHAP这样的可解释性方法对于个性化医学至关重要.
科学领域:
- 临床研究中的机器学习
- 流行病学方法 流行病学方法
- 预测建模预测建模
背景情况:
- 分类树 (CTs) 是机器学习算法,在临床研究中越来越多地用于风险分层.
- 它们的可解释的决策规则对于医疗保健专业人员来说是有价值的.
- 本综述详细介绍了CT方法及其在重症患者的"肥胖悖论"中的应用.
研究的目的:
- 为临床医生提供CT方法的严格概述.
- 用一个案例研究来说明CT在风险分层中的实用性.
- 为了比较CT方法与传统的物流回归.
主要方法:
- 描述CT开发,修剪和验证的过程.
- 在ENPIC研究数据上应用CART,CHAID和XGBoost.
- 与后勤回归进行比较,并使用SHAP值进行解释.
主要成果:
- CT测试确定了最佳的切断点和非线性预测因子相互作用.
- 确定了一个表现出肥胖悖论 (降低死亡率) 的子组.
- XGBoost显示出优异的预测性能,但解释性降低.
结论:
- CT对临床流行病学有价值,揭示了隐藏的模式并改善了风险分层.
- 合并模型提供了高精度,需要像SHAP这样的解释性技术.
- 康复医学支持个性化医疗,需要仔细的解释和验证.
相关概念视频
Survival Tree
73
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
73
Strategies for Assessing and Addressing Confounding
87
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
87
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Obesity
416
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
416
Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103


